Search

Your search keyword '"Abelaira HM"' showing total 58 results

Search Constraints

Start Over You searched for: Author "Abelaira HM" Remove constraint Author: "Abelaira HM"
58 results on '"Abelaira HM"'

Search Results

1. Intravenous administration of recombinant Phα1β: Antinociceptive properties and morphine tolerance reversal in a cancer-associated pain model.

2. Sertraline associated with gold nanoparticles reduce cellular toxicity and induce sex-specific responses in behavior and neuroinflammation biomarkers in a mouse model of anxiety.

Catalog

Books, media, physical & digital resources

3. ABO Blood Type and Metabolic Markers in COVID-19 Susceptibility and Severity: A Cross-Sectional Study.

4. Natural Phytochemicals for the Treatment of Major Depressive Disorder: A Mini-Review of Pre- and Clinical Studies.

5. Beneficial effects and neurobiological aspects of environmental enrichment associated to major depressive disorder and autism spectrum disorder.

6. Combination of electroconvulsive stimulation with ketamine or escitalopram protects the brain against inflammation and oxidative stress induced by maternal deprivation and is critical for associated behaviors in male and female rats.

7. Sex differences on the behavior and oxidative stress after ketamine treatment in adult rats subjected to early life stress.

8. Behavior and oxidative stress parameters in rats subjected to the animal's models induced by chronic mild stress and 6-hydroxydopamine.

9. Ketamine treatment protects against oxidative damage and the immunological response induced by electroconvulsive therapy.

10. Strategies for Treatment-Resistant Depression: Lessons Learned from Animal Models.

11. Early Maternal Deprivation Induces Microglial Activation, Alters Glial Fibrillary Acidic Protein Immunoreactivity and Indoleamine 2,3-Dioxygenase during the Development of Offspring Rats.

12. ω-3 and folic acid act against depressive-like behavior and oxidative damage in the brain of rats subjected to early- or late-life stress.

13. Acute treatment with ketamine and chronic treatment with minocycline exert antidepressant-like effects and antioxidant properties in rats subjected different stressful events.

14. Early life experience contributes to the developmental programming of depressive-like behaviour, neuroinflammation and oxidative stress.

15. LC/QTOF profile and preliminary stability studies of an enriched flavonoid fraction of Cecropia pachystachya Trécul leaves with potential antidepressant-like activity.

16. The impact of chronic mild stress on long-term depressive behavior in rats which have survived sepsis.

17. Mechanism of synergistic action on behavior, oxidative stress and inflammation following co-treatment with ketamine and different antidepressant classes.

18. Ketamine Exhibits Different Neuroanatomical Profile After Mammalian Target of Rapamycin Inhibition in the Prefrontal Cortex: the Role of Inflammation and Oxidative Stress.

19. Pathophysiological mechanisms involved in the relationship between diabetes and major depressive disorder.

20. Acute and chronic treatment with quetiapine induces antidepressant-like behavior and exerts antioxidant effects in the rat brain.

21. Effects of ketamine administration on mTOR and reticulum stress signaling pathways in the brain after the infusion of rapamycin into prefrontal cortex.

22. Quetiapine treatment reverses depressive-like behavior and reduces DNA methyltransferase activity induced by maternal deprivation.

23. Immune System Modulators with Antidepressant Effects: Evidence from Animal Models.

24. New perspectives on the involvement of mTOR in depression as well as in the action of antidepressant drugs.

25. Neurochemical correlation between major depressive disorder and neurodegenerative diseases.

26. Enriched Flavonoid Fraction from Cecropia pachystachya Trécul Leaves Exerts Antidepressant-like Behavior and Protects Brain Against Oxidative Stress in Rats Subjected to Chronic Mild Stress.

27. Antioxidant treatment ameliorates experimental diabetes-induced depressive-like behaviour and reduces oxidative stress in brain and pancreas.

28. Antioxidant Therapy Alters Brain MAPK-JNK and BDNF Signaling Path-ways in Experimental Diabetes Mellitus.

29. Glutamatergic NMDA Receptor as Therapeutic Target for Depression.

30. A single dose of S-ketamine induces long-term antidepressant effects and decreases oxidative stress in adulthood rats following maternal deprivation.

31. Minocycline protects against oxidative damage and alters energy metabolism parameters in the brain of rats subjected to chronic mild stress.

32. Ketamine ameliorates depressive-like behaviors and immune alterations in adult rats following maternal deprivation.

33. Ketamine treatment partly reverses alterations in brain derived- neurotrophic factor, oxidative stress and energy metabolism parameters induced by an animal model of depression.

34. Acute and Chronic Treatments with Quetiapine Increase Mitochondrial Respiratory Chain Complex Activity in the Rat Brain.

35. Anxiety disorders are associated with quality of life impairment in patients with insulin-dependent type 2 diabetes: a case-control study.

36. Animal models of social anxiety disorder and their validity criteria.

37. Epigenetic and epistatic interactions between serotonin transporter and brain-derived neurotrophic factor genetic polymorphism: insights in depression.

38. Neuroimmunomodulation in depression: a review of inflammatory cytokines involved in this process.

39. MAPK signaling correlates with the antidepressant effects of ketamine.

40. The role of mTOR in depression and antidepressant responses.

41. Cognitive dysfunction in depression: lessons learned from animal models.

42. β-Carboline harmine reverses the effects induced by stress on behaviour and citrate synthase activity in the rat prefrontal cortex.

43. Ketamine and imipramine in the nucleus accumbens regulate histone deacetylation induced by maternal deprivation and are critical for associated behaviors.

44. Ketamine alters behavior and decreases BDNF levels in the rat brain as a function of time after drug administration.

45. Effects of lamotrigine on behavior, oxidative parameters and signaling cascades in rats exposed to the chronic mild stress model.

46. Imipramine reverses alterations in cytokines and BDNF levels induced by maternal deprivation in adult rats.

47. Treatment with tianeptine induces antidepressive-like effects and alters the neurotrophin levels, mitochondrial respiratory chain and cycle Krebs enzymes in the brain of maternally deprived adult rats.

48. Animal models as tools to study the pathophysiology of depression.

49. Tianeptine exerts neuroprotective effects in the brain tissue of rats exposed to the chronic stress model.

50. Increased prevalence of mood disorders and suicidal ideation in type 2 diabetic patients.